These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28065323)

  • 41. An imaging-guided platform for synergistic photodynamic/photothermal/chemo-therapy with pH/temperature-responsive drug release.
    Lv R; Yang P; He F; Gai S; Yang G; Dai Y; Hou Z; Lin J
    Biomaterials; 2015 Sep; 63():115-27. PubMed ID: 26093792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery.
    Gao N; Yang W; Nie H; Gong Y; Jing J; Gao L; Zhang X
    Biosens Bioelectron; 2017 Oct; 96():300-307. PubMed ID: 28511113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Graphene Quantum Dots for Theranostics and Bioimaging.
    Schroeder KL; Goreham RV; Nann T
    Pharm Res; 2016 Oct; 33(10):2337-57. PubMed ID: 27207272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymer-Based Materials in Cancer Treatment: From Therapeutic Carrier and Ultrasound Contrast Agent to Theranostic Applications.
    Methachan B; Thanapprapasr K
    Ultrasound Med Biol; 2017 Jan; 43(1):69-82. PubMed ID: 27751594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
    Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery.
    Paliwal SR; Paliwal R; Vyas SP
    Drug Deliv; 2015 May; 22(3):231-42. PubMed ID: 24524308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Q&A: Omid Farokhzad on Nanomedicine in Cancer.
    Cancer Discov; 2016 Dec; 6(12):1300. PubMed ID: 27815294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multifunctional inverse opal particles for drug delivery and monitoring.
    Zhang B; Cheng Y; Wang H; Ye B; Shang L; Zhao Y; Gu Z
    Nanoscale; 2015 Jun; 7(24):10590-4. PubMed ID: 26035621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics.
    Lin CJ; Kuan CH; Wang LW; Wu HC; Chen Y; Chang CW; Huang RY; Wang TW
    Biomaterials; 2016 Jun; 90():12-26. PubMed ID: 26974704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical role for drug delivery in the development of new ophthalmic treatments.
    Sheardown H
    Future Med Chem; 2012 Nov; 4(17):2123-5. PubMed ID: 23190096
    [No Abstract]   [Full Text] [Related]  

  • 51. IVIVC of parenteral PLGA microspheres.
    Park K
    J Control Release; 2015 Nov; 218():116. PubMed ID: 26526216
    [No Abstract]   [Full Text] [Related]  

  • 52. A concise review on smart polymers for controlled drug release.
    Aghabegi Moghanjoughi A; Khoshnevis D; Zarrabi A
    Drug Deliv Transl Res; 2016 Jun; 6(3):333-40. PubMed ID: 26744179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spatial-temporal event adaptive characteristics of nanocarrier drug delivery in cancer therapy.
    Kong M; Park H; Cheng X; Chen X
    J Control Release; 2013 Nov; 172(1):281-291. PubMed ID: 24004884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preface: The Fourth Symposium on Innovative Polymers for Controlled Delivery, September 23-26, 2016, Suzhou, China.
    Zhong Z; Feijen J
    J Control Release; 2017 Aug; 259():1-2. PubMed ID: 28783486
    [No Abstract]   [Full Text] [Related]  

  • 56. Electrically controlled drug-delivery system may help minimize side effects.
    Coaker H
    Future Med Chem; 2014 Apr; 6(6):601. PubMed ID: 24895890
    [No Abstract]   [Full Text] [Related]  

  • 57. Fluorescence optical imaging in anticancer drug delivery.
    Etrych T; Lucas H; Janoušková O; Chytil P; Mueller T; Mäder K
    J Control Release; 2016 Mar; 226():168-81. PubMed ID: 26892751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Theranostic Fibers for Simultaneous Imaging and Drug Delivery.
    Jin M; Yu DG; Geraldes CF; Williams GR; Bligh SW
    Mol Pharm; 2016 Jul; 13(7):2457-65. PubMed ID: 27280491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent.
    Wu J; Zhou Y; Li S; Qu D; Zhu WH; Tian H
    Biomaterials; 2017 Mar; 120():1-10. PubMed ID: 28011190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.